Genprex

Monthly Archives: February 2022

Bringing Gene Therapies To The Masses

How one company seeks to provide hope to cancer patients through more effective treatments.

Read More

Genprex to Present at Upcoming Investor Conferences Highlighting its Gene Therapies for Cancer and Diabetes

Genprex’s President and Chief Executive Officer, Rodney Varner, will provide an overview of the Company’s gene therapies for cancer and diabetes to investors at the 2022 BIO CEO and Investor Conference and at the 2022 Diamond Equity Research Conference.

Read More